FREE Account Opening + No Clearing Fees
Loading...

Emcure Pharma IPO vs Stanley Lifestyles IPO

Comparision between Emcure Pharma IPO and Stanley Lifestyles IPO.

IPO Details

Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Stanley Lifestyles IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Emcure Pharma IPO is up to ₹1,952.03 Cr whereas the issue size of the Stanley Lifestyles IPO is up to ₹537.02 Cr. The final issue price of Emcure Pharma IPO is ₹1,008.00 per share and of Stanley Lifestyles IPO is ₹369.00 per share.

  Emcure Pharma IPO Stanley Lifestyles IPO
Face Value ₹10 per share ₹2 per share
Issue Price (Lower) ₹960.00 per share ₹351.00 per share
Issue Price (Upper) ₹1,008.00 per share ₹369.00 per share
Issue Price (Final) ₹1,008.00 per share ₹369.00 per share
Discount (Retail)
Discount (Employee) ₹90.00 per share
Market Lot Size 14 shares 40 shares
Fresh Issue Size 79,36,507 shares 54,20,054 shares
Fresh Issue Size (Amount) up to ₹800.00 Cr up to ₹200.00 Cr
OFS Issue Size 1,14,28,839 shares 91,33,454 shares
OFS Issue Size (Amount) up to ₹1,152.03 Cr up to ₹337.02 Cr
Issue Size Total 1,93,65,346 shares 1,45,53,508 shares
Issue Size Total (Amount) up to ₹1,952.03 Cr up to ₹537.02 Cr

IPO Timetable

Emcure Pharma IPO opens on Jul 03, 2024, while Stanley Lifestyles IPO opens on Jun 21, 2024. The closing date of Emcure Pharma IPO and Stanley Lifestyles IPO is Jul 05, 2024, and Jun 25, 2024, respectively.

  Emcure Pharma IPO Stanley Lifestyles IPO
Anchor Bid Date Jul 02, 2024 Jun 20, 2024
Issue Open Jul 03, 2024 Jun 21, 2024
Issue Close Jul 05, 2024 Jun 25, 2024
Basis Of Allotment (Tentative) Jul 08, 2024 Jun 26, 2024
Initiation of Refunds (Tentative) Jul 09, 2024 Jun 27, 2024
Credit of Share (Tentative) Jul 09, 2024 Jun 27, 2024
Listing date (Tentative) Jul 10, 2024 Jun 28, 2024
Anchor Lockin End date 1 Aug 07, 2024 Jul 26, 2024
Anchor Lockin End date 2 Oct 06, 2024 Sep 24, 2024

Financials

Emcure Pharma IPO P/E ratio is 34.55, as compared to Stanley Lifestyles IPO P/E ratio of 54.43.

  Emcure Pharma IPO Stanley Lifestyles IPO
Financial

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets7,806.166,672.536,063.47
Revenue6,715.246,031.725,918.86
Profit After Tax527.58561.85702.56
Net Worth2,952.282,501.131,987.55
Reserves and Surplus2,722.402,293.771,791.03
Total Borrowing2,091.942,202.422,102.19
Amount in ₹ Crore

Stanley Lifestyles Limited Financial Information (Restated Consolidated)

Stanley Lifestyles Limited's revenue increased by 42.94% and profit after tax (PAT) rose by 50.64% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets581.54458.19422.15346.52
Revenue322.29425.62297.76201.71
Profit After Tax18.7034.9823.221.92
Net Worth237.21216.50199.76182.93
Reserves and Surplus225.83207.88191.31174.96
Total Borrowing30.909.376.090.25
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 98.90% 67.36%
Promoter Shareholding (Post-Issue) 78.24% 56.81%
P/E Ratio 34.55 54.43
Market Cap ₹19029.89 Cr. ₹2103.94 Cr.
ROE 16.90%% 7.92%%
ROCE 19.37%% 8.63%%
Debt/Equity 0.67 0.86
EPS ₹29.17 ₹6.78
RoNW 16.87%% 8.34%%

Shares Offered

In the Emcure Pharma IPO retail investors (RII) are offered 67,43,160 shares while in Stanley Lifestyles IPO retail investors are offered 67,43,160 shares. Qualified institutional buyers (QIB) are offered 38,53,234 shares in Emcure Pharma IPO and 29,10,702 shares in Stanley Lifestyles IPO.

  Emcure Pharma IPO Stanley Lifestyles IPO
Anchor Investor Reserveration 57,79,850 shares 43,66,051 shares
Market Maker Reserveration
QIB 38,53,234 shares 29,10,702 shares
NII 28,89,926 shares 21,83,026 shares
RII 67,43,160 shares 50,93,728 shares
Employee 1,08,900 shares 0 shares
Others
Total 1,37,03,538 shares 1,01,87,456 shares

Bids Received (Subscription)

Emcure Pharma IPO subscribed 67.87x in total, whereas Stanley Lifestyles IPO subscribed 97.16x.

  Emcure Pharma IPO Stanley Lifestyles IPO
QIB (times) 191.24x 215.62x
NII (times) 49.32x 121.42x
Big NII (times) 54.90x 136.75x
Small NII (times) 38.16x 90.76x
RII (times) 7.36x 19.08x
Employee (times) 8.81x
Other (times)
Total (times) 67.87x 97.16x

Comments

Add a public comment...